209 related articles for article (PubMed ID: 30412089)
1. The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: A meta-analysis.
Ma JY; Ke LC; Liu Q
Medicine (Baltimore); 2018 Oct; 97(43):e12897. PubMed ID: 30412089
[TBL] [Abstract][Full Text] [Related]
2. Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio.
Yu J; Huang L; Dong T; Cao L
J Obstet Gynaecol; 2024 Dec; 44(1):2361858. PubMed ID: 38864403
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer.
Onal C; Guler OC; Yildirim BA
Int J Gynecol Cancer; 2016 Jul; 26(6):1169-75. PubMed ID: 27206286
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma.
Song W; Wang K; Zhong FP; Fan YW; Peng L; Zou SB
Oncotarget; 2016 Dec; 7(49):81830-81838. PubMed ID: 27833084
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Platelet-to-Lymphocyte Ratio in Cholangiocarcinoma: A Meta-Analysis.
Hu G; Liu Q; Ma JY; Liu CY
Biomed Res Int; 2018; 2018():7375169. PubMed ID: 30539019
[TBL] [Abstract][Full Text] [Related]
6. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery.
Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis.
Tan D; Fu Y; Su Q; Wang H
Medicine (Baltimore); 2016 Jun; 95(24):e3837. PubMed ID: 27310960
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
Tian C; Song W; Tian X; Sun Y
Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
[TBL] [Abstract][Full Text] [Related]
9. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
[TBL] [Abstract][Full Text] [Related]
10. Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer.
Zhu Y; Si W; Sun Q; Qin B; Zhao W; Yang J
Oncotarget; 2017 Jan; 8(1):1023-1030. PubMed ID: 27906679
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer.
Zhu M; Feng M; He F; Han B; Ma K; Zeng X; Liu Z; Liu X; Li J; Cao H; Liang Y; Jia C; Zhang L
Clin Chim Acta; 2018 Aug; 483():296-302. PubMed ID: 29758203
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
Leng J; Wu F; Zhang L
Front Oncol; 2022; 12():734948. PubMed ID: 35651788
[TBL] [Abstract][Full Text] [Related]
13. High Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer: A Meta-Analysis.
Zhang M; Huang XZ; Song YX; Gao P; Sun JX; Wang ZN
Biomed Res Int; 2017; 2017():9503025. PubMed ID: 29082257
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy.
Yılmaz U; Ozdemir O; Batum O; Ermin S
Indian J Cancer; 2018; 55(3):276-281. PubMed ID: 30693894
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
16. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
[No Abstract] [Full Text] [Related]
18. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.
Yodying H; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Yamada M; Uchida E
Ann Surg Oncol; 2016 Feb; 23(2):646-54. PubMed ID: 26416715
[TBL] [Abstract][Full Text] [Related]
19. Platelet-to-lymphocyte ratio associated with the clinicopathological features and prognostic value of breast cancer: A meta-analysis.
Gong Z; Xin R; Li L; Lv L; Wu X
Int J Biol Markers; 2022 Dec; 37(4):339-348. PubMed ID: 35971299
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
